Panacea Biotec Management
Management criteria checks 3/4
Panacea Biotec's CEO is Rajesh Jain, appointed in Feb 2002, has a tenure of 22.75 years. total yearly compensation is ₹9.01M, comprised of 66.6% salary and 33.4% bonuses, including company stock and options. directly owns 49.33% of the company’s shares, worth ₹12.39B. The average tenure of the management team and the board of directors is 9.5 years and 8.6 years respectively.
Key information
Rajesh Jain
Chief executive officer
₹9.0m
Total compensation
| CEO salary percentage | 66.6% |
| CEO tenure | 22.8yrs |
| CEO ownership | 49.3% |
| Management average tenure | 9.5yrs |
| Board average tenure | 8.6yrs |
Recent management updates
Recent updates
There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 34% Share Price Rise
Nov 22
There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 40% Share Price Rise
Oct 03Most Shareholders Will Probably Find That The Compensation For Panacea Biotec Limited's (NSE:PANACEABIO) CEO Is Reasonable
Sep 21Panacea Biotec Limited (NSE:PANACEABIO) Held Back By Insufficient Growth Even After Shares Climb 25%
Aug 19Does Panacea Biotec (NSE:PANACEABIO) Have A Healthy Balance Sheet?
Jun 05Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S
Apr 04Why We Think Panacea Biotec Limited's (NSE:PANACEABIO) CEO Compensation Is Not Excessive At All
Sep 23Estimating The Fair Value Of Panacea Biotec Limited (NSE:PANACEABIO)
Jul 28How Does Panacea Biotec's (NSE:PANACEABIO) CEO Pay Compare With Company Performance?
Feb 14Introducing Panacea Biotec (NSE:PANACEABIO), A Stock That Climbed 80% In The Last Five Years
Jan 06Is Panacea Biotec (NSE:PANACEABIO) Using Too Much Debt?
Sep 17
If You Had Bought Panacea Biotec (NSE:PANACEABIO) Stock A Year Ago, You Could Pocket A 78% Gain Today
Aug 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -₹147m |
| Jun 30 2024 | n/a | n/a | -₹279m |
| Mar 31 2024 | ₹9m | ₹6m | -₹12m |
| Dec 31 2023 | n/a | n/a | -₹117m |
| Sep 30 2023 | n/a | n/a | ₹99m |
| Jun 30 2023 | n/a | n/a | ₹334m |
| Mar 31 2023 | ₹8m | ₹6m | -₹332m |
| Dec 31 2022 | n/a | n/a | ₹12b |
| Sep 30 2022 | n/a | n/a | ₹11b |
| Jun 30 2022 | n/a | n/a | ₹11b |
| Mar 31 2022 | ₹8m | ₹6m | ₹11b |
| Dec 31 2021 | n/a | n/a | -₹2b |
| Sep 30 2021 | n/a | n/a | -₹2b |
| Jun 30 2021 | n/a | n/a | -₹2b |
| Mar 31 2021 | ₹7m | ₹6m | -₹1b |
| Dec 31 2020 | n/a | n/a | -₹2b |
| Sep 30 2020 | n/a | n/a | -₹1b |
| Jun 30 2020 | n/a | n/a | -₹2b |
| Mar 31 2020 | ₹8m | ₹6m | -₹2b |
| Dec 31 2019 | n/a | n/a | ₹653m |
| Sep 30 2019 | n/a | n/a | ₹715m |
| Jun 30 2019 | n/a | n/a | ₹482m |
| Mar 31 2019 | ₹7m | ₹6m | ₹410m |
| Mar 31 2018 | ₹7m | ₹6m | -₹716m |
Compensation vs Market: Rajesh's total compensation ($USD106.89K) is below average for companies of similar size in the Indian market ($USD194.11K).
Compensation vs Earnings: Rajesh's compensation has increased whilst the company is unprofitable.
CEO
Rajesh Jain (60 yo)
22.8yrs
Tenure
₹9,010,000
Compensation
Dr. Rajesh Jain, Ph D has been Managing Director at Panacea Biotec Limited since March 12, 2018 and serves as its Whole-Time Director and serves as its Chairman of the Board at Panacea Biotec Limited since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & MD | 22.8yrs | ₹9.01m | 49.33% ₹ 12.4b | |
| Joint MD & Executive Director | 22.8yrs | ₹8.37m | 15.45% ₹ 3.9b | |
| CFO & Head of Information Technology | 9.5yrs | ₹6.43m | no data | |
| Chief Scientific Officer | no data | ₹6.53m | no data | |
| Group CFO | 9.5yrs | ₹8.43m | no data | |
| Whole-Time Director | less than a year | ₹3.03m | no data | |
| Chief Operating Officer | 5yrs | no data | no data | |
| General Manager of Accounts & Taxation | no data | no data | no data | |
| Chief Information Officer | no data | no data | 0.00082% ₹ 205.9k | |
| Senior Vice President of Sales | no data | ₹5.61m | no data | |
| Senior Vice President of Human Resources | no data | ₹6.10m | no data | |
| Senior Vice President of Pharma Research & Pharma Regulatory Affairs | 5yrs | no data | no data |
9.5yrs
Average Tenure
58yo
Average Age
Experienced Management: PANACEABIO's management team is seasoned and experienced (9.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & MD | 40yrs | ₹9.01m | 49.33% ₹ 12.4b | |
| Joint MD & Executive Director | 40yrs | ₹8.37m | 15.45% ₹ 3.9b | |
| Whole-Time Director | 8.6yrs | ₹3.03m | no data | |
| Additional Non-Executive Non-Independent Director | 2.6yrs | ₹22.00k | no data | |
| Non-Executive Independent Director | 9.7yrs | ₹20.00k | no data | |
| Non-Executive Independent Director | 8.6yrs | ₹20.00k | no data | |
| Non-Executive Independent Director | less than a year | no data | no data |
8.6yrs
Average Tenure
63yo
Average Age
Experienced Board: PANACEABIO's board of directors are considered experienced (8.6 years average tenure).